Navigation Links
Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of the American Society of Clinical Oncology has published the early results of a clinical study conducted by Dr. Siu-Fun Wong, and her colleagues, which concluded that the topical gel, Regenecare(R), caused a statistically significant reduction in the pain and itching of a rash that results from the use of anti-cancer drugs known as EGFR inhibitors. This ongoing supportive care trial is listed on the National Cancer Institute Clinical Trials website (www.cancer.gov).

Paul Miller, President of MPM Medical, stated, "EGFR inhibitors form a group of drugs, sold by several pharmaceutical companies, which are effective in the treatment of cancer. However, after a few weeks of use, an acne-like rash often appears on the face, neck, back, hands, and/or legs resulting in severe pain and itching for the patient. We know of no other evidence-based topical applications reported in the scientific literature shown to help manage rash symptoms caused by EGFR drugs."

Regenecare(R) is a proprietary product of MPM Medical, Inc., a wholly owned subsidiary of RBC Life Sciences, Inc. (OTCBB:RBCL).

MPM Medical develops and markets a line of prescription and nonprescription products for wound management, through medical-surgical dealers, to nursing homes, hospitals, and cancer clinics.

The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

Contact

RBC Life Sciences, Inc.
Steve Brown, CFO, 972-893 4000
steveb@rbcls.com
www.mpmmedicalinc.com


'"/>




Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2018)... ... ... easy to get sick during cold and flu season, and when one person catches the ... can spread it to others up to about 6 feet away. Most experts think that ... talk. While most people recover from the flu within seven to ten days, it can ...
(Date:12/5/2018)... ... 2018 , ... Smile Brands Inc. has been honored with a Glassdoor Employees’ ... to 25th position on the list of the top 100 Best Places to work ... solely on the input of employees, who elect to provide feedback on their jobs, ...
(Date:12/5/2018)... ... December 04, 2018 , ... The inaugural Steven Schroeder Award for Outstanding Healthcare ... Health System in Seattle, Washington, at The Leapfrog Group ’s annual Awards Dinner ... Care , a leading non-profit dedicated to curating and disseminating insights from the frontlines ...
Breaking Medicine Technology:
(Date:12/6/2018)... (PRWEB) , ... December 06, 2018 , ... ... Wilson, Medicare Analytic Consultant Senior of Blue Cross and Blue Shield of Kansas ... Interrelated” on Tuesday, December 11, 2018 at 2:15pm PT at the Fairmont Grand ...
(Date:12/5/2018)... Tenn. and DALLAS, Texas (PRWEB) , ... December ... ... team, again proved its leading SkinPen Precision device is setting a new standard ... its record-setting Aesthetics Everything win. , Each year this award is presented at ...
(Date:12/5/2018)... ST. LOUIS PARK, Minn. (PRWEB) , ... December 05, 2018 , ... ... bringing its original, engaging, personalized fitness content to the masses. Wellbeats , which ... commercial clients, has released a new Wellbeats consumer app. Available now in the ...
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced Clinical, a clinical ... new office location in Paris, France during the Partnerships in Clinical Trials Europe ... Europe and additional in-country personnel. , “The new office broadens our CRO and ...
(Date:12/5/2018)... ... 05, 2018 , ... Northcentral University (NCU) has today announced the launch of ... on a weekly rolling basis to registered nurses, the Master of Science in ... will prepare degree candidates to become leaders in the high-demand field. , ...
Breaking Medicine News(10 mins):